Tag:
blockbuster
Latest Headlines
Latest Headlines
Biogen Idec builds blockbuster case for new MS drug BG-12
Biogen Idec is backing up its blockbuster expectations for the MS drug BG-12 with a slate of efficacy and safety data gathered in a late-stage study.
UPDATED: GSK, Theravance share mixed bag of lung drug data ahead of FDA filing
GlaxoSmithKline and Theravance have dropped another up-and-down set of data related to development of their blockbuster hopeful Relovair.
Amarin jumps on positive patent news for blockbuster hopeful
Amarin ( $AMRN ) eased some jitters over the strength of its IP protection for its lead drug AMR101 yesterday with the announcement of a notice of allowance for a U.S. patent for the formulation of its potential blockbuster cardiovascular disease drug.
Pfizer faces bumps in road with potential blockbuster RA pill
Pfizer ( $PFE ) has highlighted its experimental rheumatoid arthritis (RA) pill tofacitinib among the standouts in its pipeline, but a new survey shows that some doctors and payers might not share the pharma giant's exuberance about the program.
Okairos launches pioneering mid-stage study of promising hep C vaccine
As far as most biotech investors are concerned, the most exciting work being done in the hepatitis C field involves next-gen treatments that can potentially quell the virus without the need for the troublesome interferon in the combo.
